Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsJonathan Emberson, Werner Hacke, Jean‐Marc Olivot et al.|The Lancet|2014Cited by 2.7k
Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trialJacob Elkins, Mitchell S.V. Elkind, Roland Veltkamp et al.|The Lancet Neurology|2017Cited by 213
Functional Outcome Prediction in Acute Ischemic Stroke Using a Fused Imaging and Clinical Deep Learning ModelYongkai Liu, Greg Zaharchuk, Yannan Yu et al.|Stroke|2023Cited by 70
Alteplase for Acute Ischemic Stroke at 4.5 to 24 HoursYing Zhou, Guomin Xie, Yaode He et al.|JAMA|2025Cited by 36
Deep Learning Applications in Imaging of Acute Ischemic Stroke: A Systematic Review and Narrative SummaryBin Jiang, Greg Zaharchuk, Nancy Pham et al.|Radiology|2025Cited by 16